Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Stryker Corporation (SYK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
204.43+4.37 (+2.18%)
At close: 04:07PM EDT
205.05 +0.62 (+0.30%)
After hours: 07:41PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close200.06
Open202.04
Bid203.95 x 1100
Ask209.18 x 800
Day's Range199.93 - 205.05
52 Week Range193.34 - 281.16
Volume1,265,332
Avg. Volume1,431,717
Market Cap77.306B
Beta (5Y Monthly)1.00
PE Ratio (TTM)38.87
EPS (TTM)5.26
Earnings DateJul 25, 2022 - Jul 29, 2022
Forward Dividend & Yield2.78 (1.42%)
Ex-Dividend DateJun 29, 2022
1y Target Est281.40
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-15% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for SYK

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Stryker Corporation
    Analyst Report: Stryker CorporationStryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Nearly one fourth of Stryker's total revenue currently comes from outside the United States.
    Rating
    Fair Value
    Economic Moat
    12 days agoMorningstar
View more
Advertisement
Advertisement